290 related articles for article (PubMed ID: 29724193)
41. Formation of cofilin-actin rods following cucurbitacin-B-induced actin aggregation depends on Slingshot homolog 1-mediated cofilin hyperactivation.
Zhang YT; Ouyang DY; Xu LH; Zha QB; He XH
J Cell Biochem; 2013 Oct; 114(10):2415-29. PubMed ID: 23695982
[TBL] [Abstract][Full Text] [Related]
42. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
43. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
44. Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells.
Song X; Chen X; Yamaguchi H; Mouneimne G; Condeelis JS; Eddy RJ
J Cell Sci; 2006 Jul; 119(Pt 14):2871-81. PubMed ID: 16803871
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-300 inhibited glioblastoma progression through ROCK1.
Zhou F; Li Y; Hao Z; Liu X; Chen L; Cao Y; Liang Z; Yuan F; Liu J; Wang J; Zheng Y; Dong D; Bian S; Yang B; Jiang C; Li Q
Oncotarget; 2016 Jun; 7(24):36529-36538. PubMed ID: 27145462
[TBL] [Abstract][Full Text] [Related]
46. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.
Ling H; Ji X; Lei Y; Jia Y; Liu F; Xia H; Tan H; Zeng X; Yi L; He J; Su Q
Int J Oncol; 2020 Mar; 56(3):772-782. PubMed ID: 32124958
[TBL] [Abstract][Full Text] [Related]
47. beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2.
Zoudilova M; Min J; Richards HL; Carter D; Huang T; DeFea KA
J Biol Chem; 2010 May; 285(19):14318-29. PubMed ID: 20207744
[TBL] [Abstract][Full Text] [Related]
48. Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2.
Zoudilova M; Kumar P; Ge L; Wang P; Bokoch GM; DeFea KA
J Biol Chem; 2007 Jul; 282(28):20634-46. PubMed ID: 17500066
[TBL] [Abstract][Full Text] [Related]
49. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
50. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
51. Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties.
Hong X; Chedid K; Kalkanis SN
Int J Oncol; 2012 Nov; 41(5):1693-700. PubMed ID: 22922964
[TBL] [Abstract][Full Text] [Related]
52. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
[TBL] [Abstract][Full Text] [Related]
53. Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin.
Soosairajah J; Maiti S; Wiggan O; Sarmiere P; Moussi N; Sarcevic B; Sampath R; Bamburg JR; Bernard O
EMBO J; 2005 Feb; 24(3):473-86. PubMed ID: 15660133
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
55. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
56. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
57. Regulation of cofilin activity by CaMKII and calcineurin.
Zhao JW; Gao ZL; Ji QY; Wang H; Zhang HY; Yang YD; Xing FJ; Meng LJ; Wang Y
Am J Med Sci; 2012 Dec; 344(6):462-72. PubMed ID: 22270398
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
[TBL] [Abstract][Full Text] [Related]
59. Chronophin activation is necessary in Doxorubicin-induced actin cytoskeleton alteration.
Lee SJ; Park JW; Kang BS; Lee DS; Lee HS; Choi S; Kwon OS
BMB Rep; 2017 Jun; 50(6):335-340. PubMed ID: 28502289
[TBL] [Abstract][Full Text] [Related]
60. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
